doc. MUDr. Radek Lakomý, Ph.D.
Associate professor, Comprehensive Cancer Care Department
Total number of publications: 209
2011
-
Expression of immune-modulatory molecules HLA-G and HLA-E by tumor cells in glioblastomas: An unexpected prognostic significance?
Neuropathology, year: 2011, volume: 31, edition: 2, DOI
-
Identifikace a funkční analýza mikroRNA u pacientů s renálním karcinomem.
Year: 2011, type: Conference abstract
-
Intravenous (IF) Aflibercept versus placebo in combination with irinotecan/5-FU (FOLFIRI) for second-line treatment of metastatic colorectal cancer (MCC): Results of a multinational phase III trial (EFC10262-VELOUR)
Year: 2011, type: Conference abstract
-
Metodika CEA na příkladu temozolomidu a intratékálně aplikovaného karmustinu u pacientů s glioblastoma multiforme
Postgraduální medicína, year: 2011, volume: 13, edition: 8
-
MicroRNA in renal cell carcinoma – potential marker for prediction of early metastasis after nephrectomy.
Year: 2011, type: Conference abstract
-
MikroRNA jako nové prognostické markery časného metastazování po nefrektomii
Year: 2011, type: Conference abstract
-
MikroRNA jako nové prognostické markery časného metastazování po nefrektomii.
Year: 2011, type: Conference abstract
-
MiR-195, miR-196b, miR-181c, miR-21 expression levels and MGMT methylation status are associated with clinical outcome in glioblastoma patients.
Year: 2011, type: Conference abstract
-
MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients
Cancer Science, year: 2011, volume: 102, edition: 12, DOI
-
MiRNA-181b and miRNA-181c expression levels may predict survival and response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients.
Year: 2011, type: Conference abstract